+563.6%
AXTI vs CVS
+47.5%
+516.1%
-92.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.6% | -0.6% | -1.8% |
| 7D | -20.0% | -10.9% | -9.1% | -17.8% |
| 30D | -39.0% | -14.9% | -24.1% | -36.7% |
| 3M | -52.6% | -13.9% | -38.6% | -51.2% |
| 6M | -69.1% | -13.9% | -55.3% | -68.5% |
| YTD | +113.1% | +4.0% | +109.1% | +105.2% |
| 1Y | +244.6% | +7.8% | +236.8% | +229.4% |
| 3Y | +1,607.8% | +30.2% | +1,577.6% | +1,420.7% |
| 5Y | +295.5% | +1.6% | +293.9% | +274.5% |
| All | +563.6% | +47.5% | +516.1% | +417.1% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling